

* Biological & Medical Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; and
Departments of Physiology and Surgery, Columbia University, College of Physicians and Surgeons, New York, New York
Correspondence: Futwan Al-Mohanna, Ph.D., Biological & Medical Research, MBC 03, King Faisal Specialist Hospital & Research Centre, P.O. Box 3354, Riyadh 11211, Saudi Arabia. E-mail: futwan{at}kfshrc.edu.sa
The accumulation of advanced glycation end products (AGEs) in the tissue and serum of subjects with diabetes has been linked to the pathogenesis of vascular complications. Because diabetes may be also complicated by increased susceptibility to recurrent infection, we investigated the effects of AGEs on human neutrophils, because their burst of activity immediately upon engagement of pathogens or other inflammatory triggers is critical to host response. We demonstrate the presence of receptor for advanced glycation end products (RAGE) at the message and protein levels. We also demonstrate that AGE albumin (but not control albumin) binds with high affinity to human neutrophils (Kd of 3.7±0.4 nM). The binding was blocked almost completely by excess soluble RAGE, anti-RAGE antibodies, or antibodies to CML-modified albumin. AGE albumin induced a dose-dependent increase in intracellular-free calcium as well as actin polymerization. Further, AGE albumin inhibited transendothelial migration and Staphylococcus aureus-induced but not fMLP-induced production of reactive oxygen metabolite. Moreover, although AGE albumin enhanced neutrophil phagocytosis of S. aureus, it inhibited bacterial killing. We conclude that functional RAGE is present on the plasma membrane of human neutrophils and is linked to Ca2+ and actin polymerization, and engagement of RAGE impairs neutrophil functions.
Key Words: calcium ROM transmigration phagocytosis signal
This article has been cited by other articles:
![]() |
R. Ramasamy, S. F. Yan, and A. M. Schmidt RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts J. Leukoc. Biol., September 1, 2009; 86(3): 505 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Cho, S. M. Son, S. M. Jin, H. S. Hong, D. H. Shin, S. J. Kim, K. Huh, and I. Mook-Jung RAGE regulates BACE1 and A{beta} generation via NFAT1 activation in Alzheimer's disease animal model FASEB J, August 1, 2009; 23(8): 2639 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, J. Rich, F. Hanses, and J. C. Lee Defects in Innate Immunity Predispose C57BL/6J-Leprdb/Leprdb Mice to Infection by Staphylococcus aureus Infect. Immun., March 1, 2009; 77(3): 1008 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Omori, T. Ohira, Y. Uchida, S. Ayilavarapu, E. L. Batista Jr., M. Yagi, T. Iwata, H. Liu, H. Hasturk, A. Kantarci, et al. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase J. Leukoc. Biol., July 1, 2008; 84(1): 292 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Martens, M. C. Arikan, J. Lee, F. Ren, D. Greiner, and H. Kornfeld Tuberculosis Susceptibility of Diabetic Mice Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 518 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. McMorran, S. A. Ouvry Patat, J. B. Carlin, K. Grimwood, A. Jones, D. S. Armstrong, J. C. Galati, P. J. Cooper, C. A. Byrnes, P. W. Francis, et al. Novel Neutrophil-Derived Proteins in Bronchoalveolar Lavage Fluid Indicate an Exaggerated Inflammatory Response in Pediatric Cystic Fibrosis Patients Clin. Chem., October 1, 2007; 53(10): 1782 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karima, A. Kantarci, T. Ohira, H. Hasturk, V. L. Jones, B-H. Nam, A. Malabanan, P. C. Trackman, J. A. Badwey, and T. E. Van Dyke Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis J. Leukoc. Biol., October 1, 2005; 78(4): 862 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S Reed and M. P Pai Adjunctive Granulocyte Colony-Stimulating Factor Therapy for Diabetic Foot Infections Ann. Pharmacother., December 1, 2004; 38(12): 2150 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ward and K. R. McLeish Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure? Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1702 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peppa, H. Brem, P. Ehrlich, J.-G. Zhang, W. Cai, Z. Li, A. Croitoru, S. Thung, and H. Vlassara Adverse Effects of Dietary Glycotoxins on Wound Healing in Genetically Diabetic Mice Diabetes, November 1, 2003; 52(11): 2805 - 2813. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K.M. Wong, A. I. Pettit, P. A. Quinn, S. C. Jennings, J. E. Davies, and L. L. Ng Advanced Glycation End Products Stimulate an Enhanced Neutrophil Respiratory Burst Mediated Through the Activation of Cytosolic Phospholipase A2 and Generation of Arachidonic Acid Circulation, October 14, 2003; 108(15): 1858 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF] |
||||
![]() |
R. K.M. Wong, A. I. Pettit, J. E. Davies, and L. L. Ng Augmentation of the Neutrophil Respiratory Burst Through the Action of Advanced Glycation End Products: A Potential Contributor to Vascular Oxidant Stress Diabetes, September 1, 2002; 51(9): 2846 - 2853. [Abstract] [Full Text] [PDF] |
||||